Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: Experience in 52 patients

Thoracic and Cardiovascular Surgeon

Volumn 54, Issue 7, 2006, Pages 484-488

  Pfannschmidt, J ^a,b   Zabeck, H ^a   Muley, T ^a   Dienemann, H ^a   Hoffmann, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Thoraxklinik Heidelberg ^*  (Germany)

Author keywords

Non seminomatous testicular germ cell tumor; Prognostic factor; Thoracic surgery

Indexed keywords

CHORIONIC GONADOTROPIN; CISPLATIN; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; FIBROSIS; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROSIS; PRIORITY JOURNAL; PROGNOSIS; TERATOMA; TESTIS TUMOR; TUMOR CELL;

ADOLESCENT; ADULT; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 33750601820     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924246     Document Type: Article

References (26)

1. Sharir S, Foster RS, Donohue JP, Jewett MA. What is the appropriate follow-up after treatment? Semin Urol Oncol 1996; 14: 45-53
2. McGuire MS, Rabbani F, Mohseni H et al. The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours. BJU Int 2003; 91: 469-473
3. Kulkarni RP, Reynolds KW, Newlands ES et al. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis. Br J Surg 1991; 78: 226-229
4. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 1994; 74: 1329-1334
5. Abel U, Berger J, Wiebelt H. CRITLEVEL: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med 1984; 23: 154-156
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
7. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc A 1972; 135: 185-206
8. Fisher R. Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd, 1954
9. Cox D. Regression models and life-table (with discussion). JR Statist Soc, Series B 1972; 34: 187-220
10. Liu D, Abolhoda A, Burt ME et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 1998; 66: 1709-1714
11. Pastorino U, Buyse M, Friedel G et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113: 37-49
12. Anyanwu E, Krysa S, Buelzebruck H, Vogt-Moykopf I. Pulmonary metastasectomy as secondary treatment for testicular tumors. Ann Thorac Surg 1994; 57: 1222-1228
13. Gels ME, Hoekstra HJ, Sleijfer DT et al. Thoracotomy for postcnemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified. Chest 1997; 112: 967-973
14. Jauch KW, Koebe HG, Piltz S et al. Surgery of metastases - can surgery of metastases be radical? Zentralbl Chir 1993; 118: 508-515
15. Steyerberg EW, Keizer HJ, Zwartendijk J et al. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis. Br J Cancer 1993; 68: 195-200
16. Einhorn LH, Williams SD, Mandelbaum I, Donohue JP. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981; 48: 904-908
17. Bajorin DF, Herr H, Motzer RJ, Bosl GJ. Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 1992; 19: 148-158
18. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer 1985; 56: 860-863
19. Kesler KA, Wilson JL, Cosgrove JA et al. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience. J Thorac Cardiovasc Surg 2005; 130: 408-415
20. Cagini L, Nicholson AG, Horwich A et al. Thoracic metastasectomy for germ cell tumours: long term survival and prognostic factors. Ann Oncol 1998; 9: 1185-1191
21. Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer 1982; 50: 1629-1635
22. Stephens AW, Gonin R, Hutchins GD, Einhorn LH. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996; 14: 1637-1641
23. Kollmannsberger C, Oechsle K, Dohmen BM et al. Prospective comparison of [18F] fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Cancer 2002; 94: 2353-2362
24. Steyerberg EW, Keizer HJ, Messemer JE et al. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Cancer 1997; 79: 345-355
25. Brenner PC, Herr HW, Morse MJ et al. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. J Clin Oncol 1996; 14: 1765-1769
26. Horvath LG, McCaughan BC, Stockle M, Boyer MJ. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours. Intern Med J 2002; 32: 79-83